1. Home
  2. LZM vs AVXL Comparison

LZM vs AVXL Comparison

Compare LZM & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lifezone Metals Limited

LZM

Lifezone Metals Limited

HOLD

Current Price

$3.73

Market Cap

333.0M

ML Signal

HOLD

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$4.15

Market Cap

397.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LZM
AVXL
Founded
2021
2004
Country
Isle of Man
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
333.0M
397.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LZM
AVXL
Price
$3.73
$4.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$10.50
$22.00
AVG Volume (30 Days)
149.7K
4.3M
Earning Date
08-11-2025
11-25-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$416,323.00
N/A
Revenue This Year
$611.56
N/A
Revenue Next Year
$445.45
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.90
$2.86
52 Week High
$7.29
$14.44

Technical Indicators

Market Signals
Indicator
LZM
AVXL
Relative Strength Index (RSI) 36.78 37.24
Support Level $3.68 $3.62
Resistance Level $4.04 $4.88
Average True Range (ATR) 0.21 0.42
MACD 0.05 0.23
Stochastic Oscillator 14.61 57.56

Price Performance

Historical Comparison
LZM
AVXL

About LZM Lifezone Metals Limited

Lifezone Metals Ltd seeks to support the clean energy transition through the licensing of Hydromet Technology as an alternative to smelting and metals refining and to become an emerging supplier of responsibly sourced, lower-carbon and lower-sulfur dioxide emission metals to the battery, EV, and hydrogen markets modern pre-development exploration-stage metals company. Its business comprises three segments: Metals extraction and refining for developing and operating a vertically integrated base metal operation in the northwest region of Tanzania and Intellectual property licensing comprises patents residing with and managed by the subsidiary and corporate.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: